Recent data has shown that people with "moderate cardiovascular risk factors, peripheral arterial disease, or diabetes" who are given aspirin daily are prone to increased bleeding instead of a reduction of cardiovascular mortality. Sometimes the cardioprotective effects of aspirin are falsely advertised so aspirin therapy is dangerous, rather than beneficial for people with moderate heart disease.
The solution to this issue is for patients to be educated on methods of lowering heart disease such as "reductions in lipid levels and blood pressure, smoking cessation, and weight control through diet and exercise." Studies to test aspirin therapy are ongoing.
[Source: http://www.pharmacist.com/AM/Template.cfm?Section=Pharmacy_News&template=/CM/ContentDisplay.cfm&ContentID=23157]
No comments:
Post a Comment